You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-23. New clients entering outpatient treatment: distribution of secondary drug used at treatment in 2004: average for those EU countries supplying data

Secondary drug

Number of citations by new clients

% total number of new clients

Volatile

263

0.3

Other substances

634

0.6

Hallucinogens

1951

2.0

Hypnotics and sedatives

4547

4.6

Stimulants

9119

9.1

Opioids

9413

9.4

Cocaine

11588

11.6

Cannabis

24575

24.6

Alcohol

29983

30.0

 

 

 

Total number of new clients

 

99852

Notes

The countries supplying data are:

CZ, DK, DE, EL, IT, CY, HU, MT, NL, SI, SK, SE, UK, BG.

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab23-en.xml